Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CVS Health Corp (CVS) vs iShares MSCI Germany (DAX) (EWG) Price & Performance

CVS Health CorpTrade
iShares MSCI Germany (DAX)Trade

Price performance (Past 24H)

Key statistics

CVS Health Corp vs iShares MSCI Germany (DAX) — how do they compare? CVS Health Corp trades at $106.18 (market cap $135.48B), while iShares MSCI Germany (DAX) trades at $41.44. The key difference: CVS Health Corp pays a 2.51% dividend while iShares MSCI Germany (DAX) pays none, and CVS Health Corp is trading nearer its 52-week high, iShares MSCI Germany (DAX) nearer its low. Which is the better fit depends on your goals.

CVSEWG
Market Cap
$135.48B
Sector
HealthBroad Market / Factor
52-Week High
$106.18$44.56
52-Week Low
$58.75$38.08
Enterprise Value
$202.02B
Dividend Yield
2.51%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CVS Health Corp

CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.

The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.

iShares MSCI Germany (DAX)

EWG is trading at $41.23, down 0.63% on the day amid bearish technical signals. The stock faces selling pressure with moving averages indicating a downtrend, though oscillators remain neutral. Recent German economic developments, including healthcare reforms and ECB rate hikes, create a mixed backdrop for European-focused investments.

The outlook remains cautious with technical indicators favoring sellers, while fundamental data is unavailable. Key risks include European economic volatility and regulatory changes. Investors should monitor German economic indicators and company-specific financial disclosures for clearer direction.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS

About iShares MSCI Germany (DAX)

EWG is a country-specific ETF that tracks the performance of the German equity market. It provides exposure to large and mid-sized companies in Germany across key sectors like industrials and financials, with top holdings such as SAP, Siemens, and Allianz.

Read more on EWG